In a report released yesterday, Kyle Voigt from KBW maintained a Hold rating on Tradeweb Markets (TW – Research Report), with a price target of $100.00. The company’s shares closed yesterday at $97.37.
Voigt covers the Financial sector, focusing on stocks such as Charles Schwab, CME Group, and Marketaxess Holdings. According to TipRanks, Voigt has an average return of 5.6% and a 67.50% success rate on recommended stocks.
Currently, the analyst consensus on Tradeweb Markets is a Moderate Buy with an average price target of $104.00.
See the top stocks recommended by analysts >>
Based on Tradeweb Markets’ latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $325.72 million and a net profit of $89.08 million. In comparison, last year the company earned a revenue of $297.68 million and had a net profit of $68.34 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tradeweb Markets (TW) Company Description:
Tradeweb Markets, Inc. engages in the operation of electronic marketplaces for the trading of products across the rates, credit, money markets, and equities asset classes. It also provides related pre-trade pricing and post-trade processing services. Its network is comprised of clients across the institutional, wholesale, and retail client sectors, including global asset managers, hedge funds, insurance companies, central banks, banks and dealers, proprietary trading firms and retail brokerage and financial advisory firms, as well as regional dealers. The company was founded by Lee Olesky in 1996 and is headquartered in New York, NY.
Read More on TW:
- TW Earnings this Week: How Will it Perform?
- Tradeweb Markets price target raised to $115 from $105 at Citi
- Tradeweb Markets price target raised to $112 from $109 at Morgan Stanley
- Cboe Global Markets price target lowered to $196 from $201 at Morgan Stanley
- Ameriprise price target raised to $394 from $383 at Morgan Stanley
